Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
CYP1A2 encodes a member of the cytochrome P450 superfamily of enzymes. Additionally we are shipping CYP1A2 Kits (23) and CYP1A2 Proteins (9) and many more products for this protein.
Showing 10 out of 189 products:
Human Polyclonal CYP1A2 Primary Antibody for EIA, IF - ABIN951775
Gentile, Borro, Lala, Missori, Simmaco, Martelletti: Genetic polymorphisms related to efficacy and overuse of triptans in chronic migraine. in The journal of headache and pain 2010
Show all 5 references for ABIN951775
Human Polyclonal CYP1A2 Primary Antibody for IHC, ELISA - ABIN1534375
Corchero, Pimprale, Kimura, Gonzalez: Organization of the CYP1A cluster on human chromosome 15: implications for gene regulation. in Pharmacogenetics 2001
Mouse (Murine) Polyclonal CYP1A2 Primary Antibody for ELISA, WB - ABIN4302061
Sulem, Gudbjartsson, Geller, Prokopenko, Feenstra, Aben, Franke, den Heijer, Kovacs, Stumvoll, Mägi, Yanek, Becker, Boyd, Stacey, Walters, Jonasdottir, Thorleifsson, Holm, Gudjonsson, Rafnar et al.: Sequence variants at CYP1A1-CYP1A2 and AHR associate with coffee consumption. ... in Human molecular genetics 2011
CYP1A1 (show CYP1A1 Antibodies) and CYP1A2 localization into different lipid microdomains is governed by their N-terminal and internal protein regions
Removal of cholesterol (an important constituent of ordered domains) led to the relocation of CYP1A2, CYP2B4 and CPR (show POR Antibodies) to the disordered regions.
Oxidation kinetics of toluene in CYP1A2-CYP2B4 mixtures with and without cytochrome p450 reductase (CPR (show POR Antibodies)) are consistent with a model in which CYP1A2 has a higher affinity for CPR (show POR Antibodies) binding.
CYP1A2-163C/A polymorphism is associated with increased susceptibility to bladder cancer in the Chinese population.
Mixed-ligand copper(II) complexes activate AhR (show AHR Antibodies) and induce AhR (show AHR Antibodies)-dependent CYP (show PPIG Antibodies)!a1/2 genes in human hepatocytes.
Resulted in transient CYP1A1 (show CYP1A1 Antibodies) and CYP1A2 mRNA accumulations.
This study constructed a model of the membrane-bound full-length human P450 1A2-cyt b5 complex. The model was assembled from several parts using a multiscale modeling approach covering all-atom and coarse-grained molecular dynamics (MD).
Combined 3D-QSAR and docking procedures yielded precise information about the common and distinct interactions of inhibitors and the enzyme active sites of CYP1A2.
YP1A2 rs762551 was identified as a new potential predictive marker for early breast cancer events in AI-treated breast cancer patients. Moreover, combined genotypes of CYP1A2 rs762551 and CYP19A1 (show CYP19A1 Antibodies) rs4646 or AhR (show AHR Antibodies) Arg554Lys could further improve prediction of early AI-treatment response
The aim of the present study was to screen Uyghur volunteers for CYP1A2 genetic polymorphisms.
CYP1A2 -163A/A genotype influence carbamazepine pharmacokinetics.
niclosamide was subjected to efficient metabolic reactions hydroxylation and glucuronidation, wherein CYP1A2 and UGT1A1 (show UGT1A1 Antibodies) were the main contributing enzymes, respectively.
Pregnane X receptor (show NR1I2 Antibodies) likely regulates CYP1A2 expression in 3D spheroids of liver cancer cells.
our results suggest a more important contribution of CYP1A2 (show CYP1A1 Antibodies) to the in vivo plasma clearance and thus detoxification of 4-Aminobiphenyl
hepatic CYP1A2 (show CYP1A1 Antibodies) plays a critical role in the attenuation of hyperoxic lung injury by decreasing lipid peroxidation and oxidative stress in vivo.
Aryl hydrocarbon receptor (show AHR Antibodies) mediated induction of hepatic CYP1A1 (show CYP1A1 Antibodies)/1A2 is dependent on the presence of ctnnb1 (show CTNNB1 Antibodies).
Results indicate Cyp1a2 (show CYP1A1 Antibodies) genotype is important in susceptibility to PCB (show PC Antibodies)-induced deficits in learning and memory.
Miroestrol and deoxymiroestrol significantly up-regulated CYP2B9 while suppressing CYP1A2 (show CYP1A1 Antibodies) at both transcriptional and enzymatic levels.
A report of uroporphyria development in Cyp1a2 (show CYP1A1 Antibodies)-/- mice additionally null for both alleles of the hemochromatosis (Hfe (show HFE Antibodies)) gene and heterozygous for deletion of the uroporphyrinogen decarboxylase (Urod (show UROD Antibodies)) gene (genotype: Cyp1a2 (show CYP1A1 Antibodies)-/-;Hfe (show HFE Antibodies)-/-;Urod (show UROD Antibodies)+/-).
High levels of maternal hepatic CYP1A2 (show CYP1A1 Antibodies) protect against deficits in learning and memory in offspring exposed to a mixture of coplanar and noncoplanar PCBs; high-affinity AHR (show AHR Antibodies) is the next most important factor in protection of offspring.
In rodents, aristolochic acid demethylation, mediated by CYP1A2 (show CYP1A1 Antibodies), is a primary pathway of aristolochic acid detoxication.
The expression of Cyp1a1 (show CYP1A1 Antibodies), Cyp1a2 (show CYP1A1 Antibodies), and OGG1genes was significantly up-regulated in mice given diets containing 375 ppm dicyclanil or more.
the TRE (show TREH Antibodies) element in E1 is essential for constitutive expression of the mouse Cypla2 gene
In the present study, CYP1A2 expression in liver increased in groups exposed to single exposures of 5 mgkg-bw- 1 (p = 0.044) and 20 mgkg-bw- 1 (p = 0.033) relative to controls
This study demonstrated for the first time that the serum testosterone level is one of the physiological factors which regulate constitutive expression of hepatic CYP1A1 (show CYP1A1 Antibodies) and CYP1A2 in pigs.
The findings demonstrate a gender-related difference in the constitutive expression of hepatic CYP1A2 in Meishan pigs and further indicate that testosterone down-regulates the constitutive gene expression of the enzyme.
Purification, molecular cloning, heterologous expression and characterization of pig CYP1A2
Effect of beta-napthoflavone on AHR (show AHR Antibodies)-related gene, CYP1A2, in the pig is reported.
This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The protein encoded by this gene localizes to the endoplasmic reticulum and its expression is induced by some polycyclic aromatic hydrocarbons (PAHs), some of which are found in cigarette smoke. The enzyme's endogenous substrate is unknown\; however, it is able to metabolize some PAHs to carcinogenic intermediates. Other xenobiotic substrates for this enzyme include caffeine, aflatoxin B1, and acetaminophen. The transcript from this gene contains four Alu sequences flanked by direct repeats in the 3' untranslated region.
cytochrome P450 1A2
, Cytochrome P450-MC4
, Hepatic cytochrome P-450MC1
, cytochrome P-450 form 4
, cytochrome P-450IA2
, pulmonary cytochrome P-450MC1
, P450 LM4
, P450 isozyme 4
, cytochrome P450 isozyme 4
, cytochrome P450-PM4
, P450 form 4
, aryl hydrocarbon hydroxylase
, cytochrome P(3)450
, cytochrome P450 4
, cytochrome P450, subfamily I (aromatic compound-inducible), polypeptide 2
, cytochrome P450-P3
, dioxin-inducible P3-450
, flavoprotein-linked monooxygenase
, microsomal monooxygenase
, xenobiotic monooxygenase
, aromatic compound inducible
, cytochrome P450 family 1 subfamily a polypeptide 1
, cytochrome P450, 1a2, aromatic compound inducible
, cytochrome P450-P2
, Cytochrome P450 subfamily I (aromatic compound-inducible) member A2 (Q42 form d)
, cytochrome P-448
, cytochrome P-450d
, cytochrome P450, 1a2
, cytochrome P450, subfamily I (aromatic compound-inducible), member A2 (Q42, form d)
, cytochrome P450-D